程序化冻胚移植最佳实践的专家意见:德尔菲共识
该德尔菲共识由五人科学委员会制定17条文献与专家意见支持的陈述,由国际扩展专家组(含科学委员会成员及22名额外专家)以5点Likert量表投票,超过66%同意即达成共识。所有陈述一轮投票即超过同意阈值,涵盖程序化FET周期选择、雌激素补充途径剂量与监测、孕酮治疗途径与疗程、联合孕酮治疗、黄体支持持续时间与停止时机及不同FET方案的妊娠结局。
要点
- 程序化FET周期应由患者与医生共同决策,并根据已记录的优缺点进行个体化选择。
- 共识涵盖雌激素补充途径、剂量、持续时间及血清雌二醇、LH和孕酮监测的获益。
- 共识涉及孕酮治疗途径与持续时间、联合孕酮治疗及黄体支持停止时机。
核心结论
- 程序化FET周期的决策应由患者与医生共同做出,并根据已记录的优点(可预测性和灵活性)与缺点(不良产科和新生儿结局)进行个体化。
研究设计与样本
- 采用德尔菲共识框架,科学委员会由五名专家和一名科学协调员组成,制定17条文献支持和专家意见支持的陈述。
- 陈述提交给国际专家扩展小组(五名科学委员会成员,不包括科学协调员,另加22名专家)进行投票。
- 投票使用5点Likert量表(1=完全同意;2=比较同意;3=同意;4=不同意;5=完全不同意),超过66%参与者同意或不同意即达成共识。
主要发现
- 所有陈述在一轮投票后均超过同意阈值。
- 陈述涵盖程序化FET周期选择决策过程、雌激素补充途径剂量与持续时间及血清雌二醇、LH和孕酮监测的获益。
- 陈述涵盖孕酮治疗途径与持续时间、联合孕酮治疗的使用、黄体支持持续时间与停止时机以及不同FET方案的妊娠结局。
关键数值与推荐
- 共识阈值定为超过66%参与者同意或不同意。
- 所有17条陈述在一轮投票后均超过66%同意阈值。
临床怎么用
- 临床中程序化FET周期选择应与患者共同决策并个体化,权衡可预测性和灵活性与不良产科和新生儿结局。
- 可参考共识陈述中关于雌激素和孕酮补充途径、剂量、持续时间及监测的方案要点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: How can outcomes in programmed frozen embryo transfers (FET) be improved, and what are the key areas where more research is needed? DESIGN: Using a Delphi-consensus framework, a scientific committee comprising five experts and a Scientific Coordinator formulated 17 literature-supported and expert opinion-supported statements, which were presented to an Extended Panel of international experts (five scientific committee members, excluding the Scientific Coordinator, and an additional 22 experts) who voted on their level of agreement or disagreement with each statement using a 5-point Likert-type scale (1 = Absolutely agree; 2 = More than agree; 3 = Agree; 4 = Disagree; 5 = Absolutely disagree). Consensus was reached if over 66% of participants agreed or disagreed. RESULTS: All statements exceeded the threshold for agreement after one round of voting. The statements covered aspects such as the decision-making process for choosing a programmed FET cycle; the route, dose and duration of oestrogen supplementation, and the benefit of monitoring serum oestrogen, LH and progesterone concentrations; the route and duration of progesterone treatments; the use of combination progesterone therapy; the duration and cessation of luteal phase support; and pregnancy outcomes from different FET protocols. CONCLUSIONS: The decision to undergo a programmed FET cycle should be made jointly between the patient and the physician and should be individualized according to the documented advantages (predictability and flexibility) and disadvantages (adverse obstetric and neonatal outcomes).
引用
- Ata B, Devine K, Humaidan P, et al. Expert opinion on best practice in programmed frozen embryo transfers: a Delphi consensus. Reprod Biomed Online. 2026. PMID: 42462333. doi:10.1016/j.rbmo.2026.105820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。